BioVaxys Technology Market Cap

BioVaxys Technology has a market cap or net worth of CAD 4.41 million as of March 9, 2026. Its market cap has decreased by -74.25% in one year.

Market Cap

4.41M

Enterprise Value

4.54M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.10

Market Cap Chart

Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 4.41M, a decrease of -83.70%. That is a compound annual growth rate of -28.46%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	4.41M	-54.55%
Dec 31, 2025	9.70M	-41.13%
Dec 31, 2024	16.48M	127.10%
Dec 29, 2023	7.26M	-47.89%
Dec 30, 2022	13.92M	-26.37%
Dec 31, 2021	18.91M	32.10%
Dec 31, 2020	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
XORTX Therapeutics	4.18M
MindBio Therapeutics	3.84M
MYND Life Sciences	5.22M
ASEP Medical Holdings	3.56M
Aptose Biosciences	5.59M
Quest PharmaTech	5.92M
Gemina Laboratories	3.06M
Kane Biotech	6.36M

Market Cap Rankings